Free Trial

Akoya Biosciences (AKYA) Insider Trading & Ownership

Akoya Biosciences logo
$2.38 -0.11 (-4.42%)
(As of 02:50 PM ET)

Akoya Biosciences (NASDAQ:AKYA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
7.30%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$105,000.00
Get AKYA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Akoya Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

AKYA Insider Buying and Selling by Quarter

Akoya Biosciences Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/11/2024Brian MckelligonCEOSell7,500$2.08$15,600.00  
6/6/2024Brian MckelligonCEOSell7,500$2.01$15,075.00  
3/20/2024Brian MckelligonCEOSell7,500$4.97$37,275.00  
3/13/2024Brian MckelligonCEOSell7,500$4.94$37,050.00  
(Data available from 1/1/2013 forward)

AKYA Insider Trading Activity - Frequently Asked Questions

The list of insiders at Akoya Biosciences includes Brian Mckelligon, Frederic Pla, Garry Ph.D. Nolan, John Frederick Ek, Joseph Driscoll, and Matthew Winkler. Learn more on insiders at AKYA.

7.30% of Akoya Biosciences stock is owned by insiders. Learn more on AKYA's insider holdings.

The following insiders have purchased AKYA shares in the last 24 months: Frederic Pla ($92,000.00), John Frederick Ek ($100,000.00), and Matthew Winkler ($1,016,940.00).

Insiders have purchased a total of 243,388 AKYA shares in the last 24 months for a total of $1,208,940.00 bought.

The following insider sold AKYA shares in the last 24 months: Brian Mckelligon ($167,150.00).

Insiders have sold a total of 42,500 Akoya Biosciences shares in the last 24 months for a total of $167,150.00 sold.

Akoya Biosciences Key Executives

  • Mr. Brian McKelligon (Age 55)
    President, CEO & Director
    Compensation: $854.99k
  • Mr. John Frederick Ek (Age 48)
    CFO, Principal Financial Officer & Principal Accounting Officer
    Compensation: $496.76k
  • Dr. Frederic G. Pla Ph.D. (Age 65)
    Chief Operating Officer
    Compensation: $581.23k
  • Priyam Shah
    Senior Director of Business Development & Investor Relations Strategy
  • Ms. Jennifer Kamocsay (Age 53)
    General Counsel
  • Dr. Niro Ramachandran Ph.D. (Age 49)
    Chief Business Officer
    Compensation: $298.18k
  • Dr. Pascal Bamford Ph.D.
    Senior Vice President, Research & Development and Laboratory Operations
  • Mr. Rob C. Hart CFA
    J.D., Secretary


This page (NASDAQ:AKYA) was last updated on 12/23/2024 by MarketBeat.com Staff
From Our Partners